Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 12-2002 | |
| Sales | 1,037 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,037 | N/A | N/A | N/A | N/A |
| Operating Expenses | 3,649 | 0 | 2,380 | 1,802 | 0 |
| Operating Income | -2,612 | N/A | -2,380 | -1,802 | N/A |
| Interest Expense | 11 | 0 | 14 | 12 | 0 |
| Other Income | 41 | 0 | 14 | 13 | 0 |
| Pre-tax Income | -2,582 | 0 | -2,380 | -1,801 | 0 |
| Net Income Continuous | -2,582 | N/A | -2,380 | -1,801 | N/A |
| Net Income | $-2,582 | $N/A | $-2,380 | $-1,801 | $N/A |
| EPS Basic Total Ops | -9.04 | N/A | -1.45 | -1.14 | N/A |
| EPS Basic Continuous Ops | -0.98 | N/A | -1.12 | -0.96 | N/A |
| EPS Diluted Total Ops | -9.04 | N/A | -1.45 | -1.14 | N/A |
| EPS Diluted Continuous Ops | -0.98 | N/A | -1.12 | -0.96 | N/A |
| EBITDA(a) | $-2,454 | $N/A | $-2,316 | $-1,802 | $N/A |